{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:12:35Z","timestamp":1791000755033,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872441"],"award-info":[{"award-number":["81872441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902426"],"award-info":[{"award-number":["81902426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971737"],"award-info":[{"award-number":["81971737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic research project of Shenzhen Science and Technology Innovation Commission","award":["JCYJ20190809150409433"],"award-info":[{"award-number":["JCYJ20190809150409433"]}]},{"name":"Basic research project of Shenzhen Science and Technology Innovation Commission","award":["JCYJ20210324122612032"],"award-info":[{"award-number":["JCYJ20210324122612032"]}]},{"name":"the Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University","award":["ZSQYBRJH0003"],"award-info":[{"award-number":["ZSQYBRJH0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ovarian cancer is the most lethal gynecological cancer which is characterized by extensive peritoneal implantation metastasis and malignant ascites. Despite advances in diagnosis and treatment in recent years, the five-year survival rate is only 25\u201330%. Therefore, developing multifunctional nanomedicine with abilities of promoting apoptosis and inhibiting migration on tumor cells would be a promising strategy to improve the antitumor effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this study, we developed a novel ACaT nanomedicine composed of alendronate, calcium ions and cyclin-dependent kinase 7 (CDK7) inhibitor THZ1. With the average size of 164\u00a0nm and zeta potential of 12.4\u00a0mV, the spherical ACaT nanoparticles were selectively internalized by tumor cells and effectively accumulated in the tumor site. Results of RNA-sequencing and in vitro experiments showed that ACaT promoted tumor cell apoptosis and inhibited tumor cell migration by arresting the cell cycle, increasing ROS and affecting calcium homeostasis. Weekly intraperitoneally administered of ACaT for 8 cycles significantly inhibited the growth of tumor and prolonged the survival of intraperitoneal xenograft mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, this study presents a new self-assembly nanomedicine with favorable tumor targeting, antitumor activity and good biocompatibility, providing a novel therapeutic strategy for advanced ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-022-01300-4","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:02:45Z","timestamp":1645516965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiuyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Rong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-421X","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"1300_CR1","doi-asserted-by":"crossref","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020; 371:m3773.","DOI":"10.1136\/bmj.m3773"},{"issue":"4","key":"1300_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1300_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","volume":"216","author":"Q Gao","year":"2019","unstructured":"Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216(3):688\u2013703.","journal-title":"J Exp Med"},{"issue":"1","key":"1300_CR4","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/s41467-019-10334-6","volume":"10","author":"S Li","year":"2019","unstructured":"Li S, Ip CKM, Tang MYH, Tang MKS, Tong Y, Zhang J, et al. Sialyl Lewis-P-selectin cascade mediates tumor-mesothelial adhesion in ascitic fluid shear flow. Nat Commun. 2019;10(1):2406.","journal-title":"Nat Commun"},{"issue":"4","key":"1300_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DSP, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273\u201382.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1300_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","volume":"4","author":"M Markman","year":"2003","unstructured":"Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol. 2003;4(5):277\u201383.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1300_CR7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jso.23228","volume":"107","author":"G Glockzin","year":"2013","unstructured":"Glockzin G, von Breitenbuch P, Schlitt HJ, Piso P. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis. J Surg Oncol. 2013;107(6):574\u20138.","journal-title":"J Surg Oncol"},{"issue":"26","key":"1300_CR8","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1200\/JCO.2015.61.4776","volume":"33","author":"AA Wright","year":"2015","unstructured":"Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, et al. Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer. J Clin Oncol. 2015;33(26):2841\u20137.","journal-title":"J Clin Oncol"},{"issue":"32","key":"1300_CR9","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1200\/JCO.18.02238","volume":"37","author":"JM Del Campo","year":"2019","unstructured":"Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, et al. Niraparib maintenance therapy in patients with recurrent ovarian cancer after a partial response to the last platinum-based chemotherapy in the ENGOT-OV16\/NOVA trial. J Clin Oncol. 2019;37(32):2968\u201373.","journal-title":"J Clin Oncol"},{"key":"1300_CR10","doi-asserted-by":"publisher","first-page":"e39030","DOI":"10.7554\/eLife.39030","volume":"7","author":"M Zeng","year":"2018","unstructured":"Zeng M, Kwiatkowski NP, Zhang T, Nabet B, Xu M, Liang Y, et al. Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12\/13. eLife. 2018;7:e39030. https:\/\/doi.org\/10.7554\/eLife.39030. PMID:30422115; PMCID:PMC6251623.","journal-title":"eLife"},{"issue":"22","key":"1300_CR11","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1242\/jcs.02718","volume":"118","author":"RP Fisher","year":"2005","unstructured":"Fisher RP. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J Cell Sci. 2005;118(22):5171\u201380.","journal-title":"J Cell Sci"},{"issue":"6","key":"1300_CR12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","volume":"26","author":"CL Christensen","year":"2014","unstructured":"Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 2014;26(6):909\u201322.","journal-title":"Cancer Cell"},{"issue":"9","key":"1300_CR13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/1535-7163.MCT-17-0078","volume":"16","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Peng H, Wang X, Yin X, Ma P, Jing Y, et al. Preclinical efficacy and molecular mechanism of targeting CDK7-dependent transcriptional addiction in ovarian cancer. Mol Cancer Ther. 2017;16(9):1739\u201350.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1300_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","volume":"163","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell. 2015;163(1):174\u201386.","journal-title":"Cell"},{"issue":"7","key":"1300_CR15","first-page":"728","volume":"51","author":"H Li","year":"2020","unstructured":"Li H, Hao Y, Wang F, Wang L, Liu G. DNA nanostructures in the study of molecular interactions. Acta Polym Sin. 2020;51(7):728\u201337.","journal-title":"Acta Polym Sin"},{"key":"1300_CR16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114032","volume":"179","author":"C Chen","year":"2021","unstructured":"Chen C, Zhang Y, Chen Z, Yang H, Gu Z. Cellular transformers for targeted therapy. Adv Drug Deliv Rev. 2021;179: 114032.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"1300_CR17","doi-asserted-by":"crossref","first-page":"1700474","DOI":"10.1002\/advs.201700474","volume":"5","author":"M Wu","year":"2018","unstructured":"Wu M, Chen W, Chen Y, Zhang H, Liu C, Deng Z, et al. Focused ultrasound-augmented delivery of biodegradable multifunctional nanoplatforms for imaging-guided brain tumor treatment. Adv Sci (Weinh). 2018;5(4):1700474.","journal-title":"Adv Sci (Weinh)"},{"key":"1300_CR18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120072","volume":"250","author":"J Zhao","year":"2020","unstructured":"Zhao J, Chen G, Pang X, Zhang P, Hou X, Chen P, et al. Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy. Biomaterials. 2020;250: 120072.","journal-title":"Biomaterials"},{"issue":"2","key":"1300_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/adma.201404256","volume":"27","author":"M Wu","year":"2015","unstructured":"Wu M, Meng Q, Chen Y, Du Y, Zhang L, Li Y, et al. Large-pore ultrasmall mesoporous organosilica nanoparticles: micelle\/precursor co-templating assembly and nuclear-targeted gene delivery. Adv Mater. 2015;27(2):215\u201322.","journal-title":"Adv Mater"},{"issue":"7","key":"1300_CR20","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.nano.2016.04.013","volume":"12","author":"Q Fu","year":"2016","unstructured":"Fu Q, Hargrove D, Lu X. Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery. Nanomedicine. 2016;12(7):1951\u20139.","journal-title":"Nanomedicine"},{"issue":"26","key":"1300_CR21","first-page":"29024","volume":"12","author":"M Shariati","year":"2020","unstructured":"Shariati M, Lollo G, Matha K, Descamps B, Vanhove C, Van de Sande L, et al. Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer. ACS Appl Mater Interfaces. 2020;12(26):29024\u201336.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"1300_CR22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.nano.2018.03.005","volume":"14","author":"C Schumann","year":"2018","unstructured":"Schumann C, Chan S, Millar JA, Bortnyak Y, Carey K, Fedchyk A, et al. Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. Nanomedicine. 2018;14(4):1395\u2013405.","journal-title":"Nanomedicine"},{"key":"1300_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bioactmat.2021.06.035","volume":"8","author":"H Mei","year":"2022","unstructured":"Mei H, Cai S, Huang D, Gao H, Cao J, He B. Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification. Bioact Mater. 2022;8:220\u201340.","journal-title":"Bioact Mater"},{"issue":"1","key":"1300_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-021-01037-6","volume":"19","author":"X Shan","year":"2021","unstructured":"Shan X, Zhang X, Wang C, Zhao Z, Zhang S, Wang Y, et al. Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy. J Nanobiotechnol. 2021;19(1):282.","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"1300_CR25","doi-asserted-by":"crossref","first-page":"1907857","DOI":"10.1002\/adfm.201907857","volume":"30","author":"K Ou","year":"2020","unstructured":"Ou K, Xu X, Guan S, Zhang R, Zhang X, Kang Y, et al. Nanodrug carrier based on poly (ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater. 2020;30(9):1907857.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"1300_CR26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12951-020-00679-2","volume":"18","author":"R Wang","year":"2020","unstructured":"Wang R, Yang Y, Yang M, Yuan D, Huang J, Chen R, et al. Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein\/DOX nanodispersions. J Nanobiotechnol. 2020;18(1):116.","journal-title":"J Nanobiotechnol"},{"issue":"50","key":"1300_CR27","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1073\/pnas.1421410111","volume":"111","author":"T Yuen","year":"2014","unstructured":"Yuen T, Stachnik A, Iqbal J, Sgobba M, Gupta Y, Lu P, et al. Bisphosphonates inactivate human EGFRs to exert antitumor actions. Proc Natl Acad Sci U S A. 2014;111(50):17989\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1300_CR28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/0008-5472.540.65.2","volume":"65","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Morishige K-I, Sawada K, Tahara M, Kawagishi R, Ikebuchi Y, et al. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model. Cancer Res. 2005;65(2):540\u20135.","journal-title":"Cancer Res"},{"key":"1300_CR29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","volume":"6","author":"A G\u00f6rlach","year":"2015","unstructured":"G\u00f6rlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: a mutual interplay. Redox Biol. 2015;6:260\u201371.","journal-title":"Redox Biol"},{"issue":"15","key":"1300_CR30","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007426","volume":"33","author":"P Zheng","year":"2021","unstructured":"Zheng P, Ding B, Shi R, Jiang Z, Xu W, Li G, et al. A multichannel Ca nanomodulator for multilevel mitochondrial destruction-mediated cancer therapy. Adv Mater. 2021;33(15): e2007426.","journal-title":"Adv Mater"},{"key":"1300_CR31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","volume":"4","author":"S Orrenius","year":"2003","unstructured":"Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4:552\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1300_CR32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(95)90430-1","volume":"82","author":"G Hajn\u00f3czky","year":"1995","unstructured":"Hajn\u00f3czky G, Robb-Gaspers LD, Seitz MB, Thomas AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell. 1995;82:415\u201324.","journal-title":"Cell"},{"key":"1300_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00762734","volume":"26","author":"RG Hansford","year":"1994","unstructured":"Hansford RG. Physiological role of mitochondrial Ca2+ transport. J Bioenerg Biomembr. 1994;26:495\u2013508.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"1300_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbcan.2018.04.011","volume":"1870","author":"DE Biancur","year":"2018","unstructured":"Biancur DE, Kimmelman AC. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochim Biophys Acta Rev Cancer. 2018;1870(1):67\u201375.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1300_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcis.2021.07.080","volume":"605","author":"J Chen","year":"2022","unstructured":"Chen J, Qiu M, Zhang S, Li B, Li D, Huang X, et al. A calcium phosphate drug carrier loading with 5-fluorouracil achieving a synergistic effect for pancreatic cancer therapy. J Colloid Interface Sci. 2022;605:263\u201373.","journal-title":"J Colloid Interface Sci"},{"issue":"26","key":"1300_CR36","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.1039\/C8DT00241J","volume":"47","author":"A Nsubuga","year":"2018","unstructured":"Nsubuga A, Sgarzi M, Zarschler K, Kubeil M, H\u00fcbner R, Steudtner R, et al. Facile preparation of multifunctionalisable \u201cstealth\u201d upconverting nanoparticles for biomedical applications. Dalton trans. 2018;47(26):8595\u2013604.","journal-title":"Dalton trans"},{"issue":"5","key":"1300_CR37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00198-008-0725-9","volume":"20","author":"AL Boskey","year":"2009","unstructured":"Boskey AL, Spevak L, Weinstein RS. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int. 2009;20(5):793\u2013800.","journal-title":"Osteoporos Int"},{"key":"1300_CR38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.enzmictec.2015.12.008","volume":"84","author":"M Misson","year":"2016","unstructured":"Misson M, Du X, Jin B, Zhang H. Dendrimer-like nanoparticles based \u03b2-galactosidase assembly for enhancing its selectivity toward transgalactosylation. Enzyme Microb Technol. 2016;84:68\u201377.","journal-title":"Enzyme Microb Technol"},{"issue":"10","key":"1300_CR39","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/molecules24101851","volume":"24","author":"P Wang","year":"2019","unstructured":"Wang P, Li Y, Ding L, Cao S, Wang L, Qiu F. Six new methyl apiofuranosides from the bark of Schneid and their inhibitory effects on nitric oxide production. Molecules. 2019;24(10):1851.","journal-title":"Molecules"},{"issue":"6","key":"1300_CR40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.chembiol.2019.02.012","volume":"26","author":"CM Olson","year":"2019","unstructured":"Olson CM, Liang Y, Leggett A, Park WD, Li L, Mills CE, et al. Development of a selective CDK7 covalent inhibitor reveals predominant cell-cycle phenotype. Cell Chem Biol. 2019;26(6):792\u2013803.","journal-title":"Cell Chem Biol"},{"issue":"20","key":"1300_CR41","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1158\/1078-0432.CCR-18-3788","volume":"25","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhou L, Bandyopadhyay D, Sharma K, Allen AJ, Kmieciak M, et al. The covalent CDK7 inhibitor THZ1 potently induces apoptosis in multiple myeloma cells in vitro and in vivo. Clin Cancer Res. 2019;25(20):6195\u2013205.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1300_CR42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7150\/ijbs.39779","volume":"16","author":"H Chen","year":"2020","unstructured":"Chen H, Huang C, Xu Q, Li F, Huang X, Wang J, et al. Therapeutic targeting of CDK7 suppresses tumor progression in intrahepatic cholangiocarcinoma. Int J Biol Sci. 2020;16(7):1207\u201317.","journal-title":"Int J Biol Sci"},{"issue":"21","key":"1300_CR43","first-page":"6015","volume":"62","author":"K Sawada","year":"2002","unstructured":"Sawada K, Morishige K-I, Tahara M, Kawagishi R, Ikebuchi Y, Tasaka K, Murata Y. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer Res. 2002;62(21):6015\u201320.","journal-title":"Cancer Res"},{"issue":"5","key":"1300_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjp.0706373","volume":"9146","author":"R Inoue","year":"2005","unstructured":"Inoue R, Matsuki N-A, Jing G, Kanematsu T, Abe K, Hirata M. The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells. Br J Pharmacol. 2005;9146(5):633\u201341.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1300_CR45","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.20190251","volume":"216","author":"M Zarei","year":"2019","unstructured":"Zarei M, Du H, Nassar AH, Yan RE, Giannikou K, Johnson SH, et al. Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. J Exp Med. 2019;216(11):2635\u201352.","journal-title":"J Exp Med"},{"issue":"1","key":"1300_CR46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12951-021-00933-1","volume":"19","author":"H Hu","year":"2021","unstructured":"Hu H, Yang W, Liang Z, Zhou Z, Song Q, Liu W, et al. Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy. J Nanobiotechnol. 2021;19(1):221.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"1300_CR47","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1021\/acs.nanolett.0c04778","volume":"21","author":"P Zheng","year":"2021","unstructured":"Zheng P, Ding B, Jiang Z, Xu W, Li G, Ding J, et al. Ultrasound-augmented mitochondrial calcium ion overload by calcium nanomodulator to induce immunogenic cell death. Nano Lett. 2021;21(5):2088\u201393.","journal-title":"Nano Lett"},{"issue":"1","key":"1300_CR48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fon.12.171","volume":"9","author":"S Hallaj-Nezhadi","year":"2013","unstructured":"Hallaj-Nezhadi S, Dass CR, Lotfipour F. Intraperitoneal delivery of nanoparticles for cancer gene therapy. Future Oncol. 2013;9(1):59\u201368.","journal-title":"Future Oncol"},{"issue":"2","key":"1300_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jconrel.2008.04.014","volume":"130","author":"J Intra","year":"2008","unstructured":"Intra J, Salem AK. Characterization of the transgene expression generated by branched and linear polyethylenimine\u2013plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Rel. 2008;130(2):129\u201338.","journal-title":"J Control Rel"},{"issue":"10","key":"1300_CR50","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","volume":"124","author":"HA Kenny","year":"2014","unstructured":"Kenny HA, Chiang CY, White EA, Schryver EM, Habis M, Romero IL, et al. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest. 2014;124(10):4614\u201328.","journal-title":"J Clin Invest"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01300-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:37:14Z","timestamp":1700242634000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01300-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1192880\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"25 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Care and Use Committee (SYSU-IACUC-2021-B0815) of Sun Yat-sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}